In this episode, Christina Busmalis and Sabine dive deep into the evolving intersection of AI and drug development.
Category: Podcast Articles
Cut the Chat Life Science Insider Podcast
Tune into our Podcast category for the latest seasons and episodes of the “Cut the Chat Life Science Insider” podcast by Seuss+.
Here, we announce new episodes and share synopses that dive deep into the heart of life science discussions, featuring insights from industry experts and insiders.
Get ready for thought-provoking content designed to enlighten and inspire professionals within the life sciences sector.
S2 E3 – Transforming Clinical Trials: How Digital Endpoints Are Leading the Way
S2 E3 Explore how digital endpoints are revolutionizing clinical trials, featuring insights from Victoria Bangieva and Lauren Alani. Don’t miss it.
S2 E2 – Navigating the Commercialization Journey: Insights from Science to Market
Dive into the crucial aspects of biotech commercialization with Kirsten Detrick on Season 2, Episode 2 of the Cut The Chat Podcast. Learn why early commercialization strategies matter and discover key insights from a seasoned biotech executive.
S2 E1 – Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions
Tune in to Cut The Chat’s Season 2, Episode 1 as Seuss+ CEO Sabine Hutchison explores with Stephanie Oestreich of MIF the intersections of investment, scientific breakthroughs, and the quest for a Myeloma cure. Dive into a conversation about the challenges and triumphs of specialty funds and the impact of strategic investments on clinical trials.
Episode 5 – Mastering the Art of Collaboration: Principal Investigator and Biotech Dynamics
Episode Five of Cut the Chat – Life Science Insider. Vivian van de Walle unfolds as a captivating exploration of the pivotal role effective collaboration plays in the intersection of science and business within the biotech landscape.
Episode 4 – Cross-Pollination and Embedding DEI Strategies within Biotechs
Episode Four of Cut the Chat – Life Science Insider. Our guest speaker, Ben Osborn, Eastern Cluster President at IDM, Biopharma, Pfizer will share his extensive knowledge and insights on the crucial topic of DEI.
Episode 3 – Cracking the code: Navigating the Ever-Changing Biotech Landscape
Today we embark on an insightful journey to explore the strategies employed by Allison and learn from experiences. There are many challenges which biotech’s deal with, our quest today leads us to tackle four hurdles that biotech companies encounter in their pursuit of innovation and life-changing breakthroughs.
Episode 2 Innovation Unleashed: Exploring the Intersection of Science and Creativity – An Unconventional Growth Strategy
Biotech Science and Creativity: We sit down with Dr. Jennifer Buell, President and CEO of Mint Therapeutics and Chairman of the Executive Council at Agenus Bio
Episode 1 Smart KPIs for Biotechs
Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits down with Sabine to discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
We can help you